Keith Goldan Insider Profile
4 Followers
Keith Goldan, SVP and CFO at Fibrocell Science, holds 139.25K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds 32.75K shares in Abeona Therapeutics (Ticker: ABEO), holds 141.73K shares in Optinose (Ticker: OPTN). Most recently, Keith Goldan Sold ― shares of Syndax Pharmaceuticals on Jun 02, 2026 for an estimated value of $22.35K.
Profitable Transactions
4 out of 8 Profitable Transactions
Average Return
-25.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Keith Goldan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Keith Goldan
Keith Goldan's Trading History
Fibrocell Science
Aug 11, 2015
―
Informative Buy
12.66K
$6.00K
Optinose
Mar 17, 2022
―
Uninformative Sell
9.74K
$1.36M
Syndax Pharmaceuticals
Jun 02, 2026
CFO
Informative Sell
22.35K
$2.65M
Abeona Therapeutics
Apr 07, 2026
Director
Uninformative Buy
―
$188.97K
Nupathe Inc
Feb 25, 2014
―
Uninformative Sell
1.13M
―
List of latest transactions for each holding click on a transaction to see Keith Goldan's performance on stock
You May Also Like
Keith Goldan insider profile FAQ
What is the percentage of profitable transactions made by Keith Goldan?
The percentage of profitable transactions made by Keith Goldan is 50%.
What is the average return per transaction made by Keith Goldan?
The average return per transaction made by Keith Goldan is -25.80%.
What stocks does Keith Goldan hold?
Keith Goldan holds: FCSC, OPTN, SNDX, ABEO, ~PATH stocks.
What was Keith Goldan’s latest transaction?
Keith Goldan latest transaction was an Informative Sell of $22.35K.
What was Keith Goldan's most profitable transaction?
Keith Goldan’s most profitable transaction was an Informative Sell of SNDX stock on February 10, 2026. The return on the trade was 14.30%.
What is Keith Goldan's role in Fibrocell Science?
Keith Goldan's role in Fibrocell Science is SVP and CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.